National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 1338187

Government Disclaimer on use of this data

Case Details

VAERS ID: 1338187 (history)  
Form: Version 2.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Death, General physical health deterioration, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-27
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: PAMOL; RISPERDAL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asthma; Dementia NOS; Osteoarthritis
Diagnostic Lab Data: Test Date: 202104; Test Name: body temperature; Result Unstructured Data: Test Result:over 38.0 Centigrade; Comments: 17-19Apr2021 fever over 38.0 degrees; Test Date: 202104; Test Name: body temperature; Result Unstructured Data: Test Result:37.2 - 37.4 Centigrade; Comments: 20-26Apr2021 mild warming (37.2 - 37.4. Degrees)
CDC Split Type: FIPFIZER INC2021560871

Write-up: Exitus; recent fading of the well-being; fever; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB, regulatory authority number FI-FIMEA-20212573. A 92-years-old female patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 15Apr2021 (Batch/Lot Number: EW2246) as single dose for covid-19 immunisation. Medical history included asthma, osteoarthritis, unspecified dementia. No known allergies. Concomitant medications included paracetamol (PAMOL) taken for an unspecified indication, start and stop date were not reported; risperidone (RISPERDAL) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 for covid-19 immunization with no side effects. 17-19Apr2021 fever over 38.0 degrees without changes in inflammatory values or other symptoms of infection. No detectable infection focus. 20-26Apr2021 mild warming (37.2 - 37.4 Degrees) and recent fading of the well-being. Hospice decision 26Apr2021. Exitus 27Apr2021. Prolonged fever after COVID 19 vaccine without evidence of infection. The outcome of the events fever and ''fading of the well-being'' was unknown. The patient died on 27Apr2021. It was unknown if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Exitus

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166